hsa-mir-876: Hsa-mir-876 is a microRNA that has been studied in relation to endometrial cancer (EC) [PMC9318842]. In a study comparing EC tissues and adjacent non-tumor tissues, there was no significant difference in the expression of hsa-mir-876 between the two [PMC9318842]. However, hsa-mir-876 has been identified as one of the indicators that can be used to predict the survival rate of EC patients [PMC9318842]. Additionally, hsa-mir-876 was found to be downregulated with a deletion in DNA codifying for the pri- or pre-miRNA in a combination of deregulated miRNA and their copy number alterations (CNAs) [PMC5877771]. Furthermore, an integrated bioinformatics approach identified hsa-mir-876 as one of the nine m7G-related miRNAs associated with the survival of uterine corpus endometrial carcinoma (UCEC) patients [PMC9713471]. In UCEC patients, high expression levels of hsa-mir-876 were associated with significantly lower survival rates compared to those with low expression levels [PMC9713471]. In summary, hsa-mir-876 is a microRNA that has been studied in relation to EC and UCEC. While its expression levels did not significantly differ between EC tissues and adjacent non-tumor tissues, it can be used as an indicator for predicting the survival rate of EC patients. Additionally, alterations in DNA codifying for hsa-mir-876 have been observed. In UCEC patients, high expression levels of hsa-mir-876 were associated with lower survival rates.